In the present study, we demonstrated that SLC1A5 (ASCT2) expression was regulated through KRAS signaling, and that SLC1A5-knockdown resulted in reduced cell growth and increased cell apoptosis in KRAS-mutant CRC cells (Figure 1 and Figure 3). The gene discussed is KRAS; the disease is colorectal carcinoma.